Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Fluorescence Imaging During Robotic Prostatectomy
NCT02119858Phase 1Completed
- Sponsor
- City of Hope
- Start
- Aug 2014
- Primary completion
- Feb 2018
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of indocyanine green in prostate cancer (PCa), sponsored by City of Hope. Primary endpoint: Intraoperative detection of fluorescence in pelvic lymphatic tissue. Started Aug 2014; status: completed.
02
Drugs
indocyanine green
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02119858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02119858.